Alaska Wealth Advisors bought a new position in Bristol-Myers Squibb (NYSE:BMY – Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 29,787 shares of the biopharmaceutical company’s stock, valued at approximately $1,528,000. Bristol-Myers Squibb makes up about 0.3% of […]